SPECTRUM PHARMACEUTICALS INC Quarterly Other Assets, Noncurrent in USD from Q4 2010 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Spectrum Pharmaceuticals Inc quarterly Other Assets, Noncurrent history and growth rate from Q4 2010 to Q1 2023.
  • Spectrum Pharmaceuticals Inc Other Assets, Noncurrent for the quarter ending March 31, 2023 was $245K, a 94.4% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 $245K -$4.1M -94.4% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $157K -$4.48M -96.6% Dec 31, 2022 10-Q 2023-05-11
Q3 2022 $3.66M -$757K -17.1% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $3.8M -$527K -12.2% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $4.35M -$15K -0.34% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $4.64M +$309K +7.14% Dec 31, 2021 10-K 2023-03-31
Q3 2021 $4.42M +$421K +10.5% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $4.33M +$729K +20.3% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $4.36M +$1.18M +36.9% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $4.33M +$327K +8.18% Dec 31, 2020 10-K 2022-03-18
Q3 2020 $3.99M -$4.62M -53.6% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 $3.6M -$4.68M -56.5% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $3.19M -$4.99M -61% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $4M -$3.19M -44.4% Dec 31, 2019 10-K 2021-03-31
Q3 2019 $8.61M -$1.76M -17% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $8.28M -$4.88M -37.1% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $8.18M -$9.93M -54.8% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $7.19M -$46.6M -86.6% Dec 31, 2018 10-K 2020-03-02
Q3 2018 $10.4M -$25.4M -71% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 $13.2M -$13.5M -50.7% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 $18.1M -$12.6M -41% Mar 31, 2018 10-Q 2018-05-04
Q4 2017 $53.8M +$24.2M +82% Dec 31, 2017 10-K 2019-02-28
Q3 2017 $35.7M +$7.72M +27.6% Sep 30, 2017 10-Q 2017-11-03
Q2 2017 $26.7M +$1.08M +4.23% Jun 30, 2017 10-Q 2017-08-04
Q1 2017 $30.7M +$5.38M +21.3% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 $29.5M +$10.3M +53.8% Dec 31, 2016 10-K 2018-03-07
Q3 2016 $28M +$10.2M +57% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 $25.6M +$5.65M +28.3% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 $25.3M +$6.5M +34.5% Mar 31, 2016 10-Q 2016-05-06
Q4 2015 $19.2M +$1.35M +7.54% Dec 31, 2015 10-K 2017-03-14
Q3 2015 $17.8M -$3.31M -15.7% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 $20M +$4.76M +31.3% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 $18.8M +$5.19M +38.1% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 $17.9M +$5.29M +42% Dec 31, 2014 10-K 2016-03-14
Q3 2014 $21.2M +$12.5M +146% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 $15.2M +$1.63M +12% Jun 30, 2014 10-Q 2014-08-08
Q1 2014 $13.6M +$4.25M +45.4% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 $12.6M +$5.83M +86.5% Dec 31, 2013 10-K 2015-03-13
Q3 2013 $8.61M +$2.39M +38.3% Sep 30, 2013 10-Q 2013-11-18
Q2 2013 $13.6M +$10.7M +377% Jun 30, 2013 10-Q 2013-08-09
Q1 2013 $9.37M +$7.01M +298% Mar 31, 2013 10-Q 2013-05-09
Q4 2012 $6.75M +$5.38M +396% Dec 31, 2012 10-K 2014-03-12
Q3 2012 $6.23M +$5.65M +981% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 $2.85M +$2.47M +651% Jun 30, 2012 10-Q 2012-08-08
Q1 2012 $2.36M Mar 31, 2012 10-Q 2012-04-27
Q4 2011 $1.36M +$927K +214% Dec 31, 2011 10-K 2013-02-28
Q3 2011 $576K Sep 30, 2011 10-Q 2011-10-28
Q2 2011 $379K Jun 30, 2011 10-Q 2011-08-04
Q4 2010 $434K Dec 31, 2010 10-K 2012-03-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.